1. Home
  2. PAHC vs VERA Comparison

PAHC vs VERA Comparison

Compare PAHC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$40.78

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$47.84

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAHC
VERA
Founded
1946
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
PAHC
VERA
Price
$40.78
$47.84
Analyst Decision
Hold
Strong Buy
Analyst Count
4
10
Target Price
$31.25
$67.67
AVG Volume (30 Days)
273.3K
1.9M
Earning Date
02-04-2026
11-05-2025
Dividend Yield
1.18%
N/A
EPS Growth
288.74
N/A
EPS
1.67
N/A
Revenue
$1,399,676,000.00
N/A
Revenue This Year
$15.34
N/A
Revenue Next Year
$3.28
N/A
P/E Ratio
$24.30
N/A
Revenue Growth
33.72
N/A
52 Week Low
$16.16
$18.53
52 Week High
$46.42
$51.19

Technical Indicators

Market Signals
Indicator
PAHC
VERA
Relative Strength Index (RSI) 48.75 74.43
Support Level $39.39 $40.38
Resistance Level $41.62 $51.19
Average True Range (ATR) 1.66 3.37
MACD -0.02 0.56
Stochastic Oscillator 63.50 81.92

Price Performance

Historical Comparison
PAHC
VERA

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: